The Senza Spinal Cord Stimulation (SCS) System is a type of neuromodulation technology, using an implanted pacemaker-like device to deliver electrical impulses to the spinal cord for chronic intractable pain of the trunk or limbs. It involves application of high frequency (10 kHz), short duration (30 ┬Ásec), low-amplitude (1-5 mA) pulses to the T8-T11 spinal epidural space in a specific treatment algorithm. This is known as HF10 therapy.
 
 
Status In progress
Process MT
ID number 330

Provisional Schedule

Draft guidance 06 November 2017 - 04 December 2017
Committee meeting: 3 08 December 2017
Resolution 22 January 2018
Expected publication 05 March 2018

Project Team

Project lead Liesl Millar

Email enquiries

Stakeholders

External assessment group Newcastle & York Consortium
Manufacturers Nevro Corporation
Manufacturers of related technologies not included in scope Medtronic Limited
  Abbott
  Boston Scientific
Others Department of Health (DH)
  Healthcare Improvement Scotland (HIS)
  Johnson & Johnson Medical Ltd
  National Institute for Health Research Horizon Scanning Centre (NIHR)
  Medicines and Healthcare Products Regulatory Agency (MHRA)
  NHS England (NHSE)
  The James Cook University Hospital
  Health Quality Transformation
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Royal College of Physicians
  British Society of Rehabilitation Medicine
  British Pain Society
  Devices for Dignity
  Medical Technology Group
  The British In Vitro Diagnostics Association (BIVDA)
  Neuromodulation Society of UK and Ireland (NSUKI)

Timeline

Key events during the development of the guidance:

Date Update
22 September 2017 Committee meeting: 2
23 May 2017 Scope published
26 April 2017 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance